SORLA and SORCS1 act as neuronal receptors for the amyloid precursor protein (APP) controlling proteolytic breakdown of this precursor into neurotoxic amyloid-β peptides, a pathological mechanism in Alzheimer’s disease [11,12,13,14,15]. This evidence concerns the gene APP and early-onset autosomal dominant Alzheimer disease.